Greene Concepts Cancels All Convertible Debt and Strengthens Financial Position
Marion, North Carolina--(Newsfile Corp. - October 8, 2024) - Greene Concepts Inc. (OTC Pink: INKW) is pleased to announce the...
Day: October 8, 2024
Avenues Recovery Center to Open New 146-Bed Residential Addiction Treatment Facility in Baton Rouge
BATON ROUGE, LA / ACCESSWIRE / October 8, 2024 / Avenues Recovery Center is proud to announce the anticipated grand...
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
SAN FRANCISCO, CA / ACCESSWIRE / October 8, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") today announced that a late-breaking abstract...
The Global Biopharma Community is Now Actively Partnering for BIO-Europe(R) 2024
MUNICH, GERMANY / ACCESSWIRE / October 8, 2024 / The 30th annual BIO-Europe, the premier partnering conference for the global...
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Findings show care for chronic liver disease patients is falling on non-specialists who need stronger education and support to ensure...
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
"Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth."SCOTTSDALE, AZ /...
Sunknowledge Achieves ISO 27001:2022 Certification, Setting a New Benchmark for Data Security
Enhancing Client Trust with ISO 27001:2022: Sunknowledge Strengthens Data Protection NEW YORK CITY, NY / ACCESSWIRE / October 8, 2024...
Interactive Strength Inc. (Nasdaq:TRNR) Enters the Medical channel for the first time by Exhibiting FORME at APTA Private Practice Annual Conference on October 9-12
The medical channel, and specifically physical therapy, is a new channel for FORMEWOODWAY has been in the medical channel for...
NanoViricides to Present at the Global AMR Summit 2024 Tomorrow
Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /...
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA
TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a...
Parexel’s Teri Karcher Named to 2024 PharmaVoice 100
Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence recognized for pioneering leadership in drug development DURHAM,...
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments...
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
AI (Artificial Intelligence) and ML (Machine Learning) drug discovery collaboration will accelerate the development of small molecules as orally available...
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
Live webcast fireside chat on Tuesday, October 15th at 2:30 PM ET THE WOODLANDS, TX, Oct. 08, 2024 (GLOBE NEWSWIRE)...
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities
DENVER , Oct. 08, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to...
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
REDWOOD CITY, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Cerevance Achieves Second Milestone in Research Collaboration with Merck
BOSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment...
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
VANCOUVER, Washington, Oct. 08, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet...